What Has Been The Evolution of the Metabolomics Market in Recent Years?
The metabolomics market has seen considerable growth due to a variety of factors.
• The market size for metabolomics has been rapidly expanding in recent years. Its valuation is projected to escalate from $3.62 billion in 2024 to $4.18 billion in 2025, with a compound annual growth rate (CAGR) of 15.4%.
The accelerated growth rate experienced in the previous years is due to progressions in the sectors of healthcare, pharmaceutical development and discovery, identification of disease biomarkers, academic studies, research facilities, and food science and nutrition.
What Is the Forecasted Market Size and Growth Rate for The Metabolomics Market Size In The Coming Years?
The metabolomics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a swift expansion is forecasted for the metabolomics market. It is projected to reach a valuation of $7.99 billion by 2029, at a compound annual growth rate of 17.6%.
This upswing in the prediction timeframe can be credited to factors like personalized healthcare, drug safety and efficacy, microbiome and gut health, as well as environmental and agricultural applications and regenerative medicine. During this forecast period, significant trends such as integration with other omics, action towards targeted metabolomics, single-cell metabolomics, data analytics and AI, along with point-of-care testing are expected to gain prominence.
What Factors Are Driving Growth In The Metabolomics Market?
The growth of the metabolomics market is fueled by the surging incidence rate of cancer. Metabolomics employs the screening of potential biomarkers (such as specific cells, genes, gene products, molecules, enzymes, or hormones) to gauge the responsiveness of cancer drugs, thus assisting early detection. For example, the American Cancer Society, a professional organization based in the US, forecasts that in 2023, new cancer cases and deaths are expected to reach 1,958,310 and 609,820 respectively in the US, showing an increase from the prior year. Techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS) have been utilized in cancer research through metabolomics. Companies such as Metabolon Inc. and Bruker Corp., among others, have incorporated metabolomics as a strategy for early cancer detection and treatment.
What Are The Main Segments Of The Global Metabolomics Market?
The metabolomics market covered in this report is segmented –
1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments:
1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance), Others (Spectroscopy Instruments, Microarrays)
2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services
Pre-Book The Metabolomics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Metabolomics Market?
The relevance and use of machine learning are rapidly expanding in the metabolomics sector due to its ability to enhance the interpretation of data derived from metabolomics methods. The technologies empowered by machine learning facilitate the automatization of risky and intricate operations, eliminate redundant and time-consuming processes, and deliver swift and precise services. In the industry, corporations are increasingly favoring machine learning approaches for metabolic analysis to address challenges, streamline processes, and carry out tasks. Several machine learning algorithms assist in the analysis of metabolic data and the modeling of metabolic pathways. Companies like Bio-Rad Laboratories, Metabolon Inc., among others, have begun leveraging machine learning algorithms to gain deeper insights and make more accurate predictions in metabolomics research. For instance, MeltDB 2.0, a machine learning software, is utilized as a tool for analyzing and integrating metabolomics experimental data, aiding research, and storing experimental data sets. Such machine learning software provides comprehensive analysis and visualisation capabilities for the optimal representation of intricate, vast sets of data.
Who Are the Key Players In The Metabolomics Market?
Major companies operating in the metabolomics market include:
• Human Metabolome Technologies Inc.
• Metabolon Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Biocrates Life Sciences AG
• Shimadzu Corporation
• Danaher Corporation
• Kore Technologies Ltd.
• Dani Instruments SpA
• Perkinelmer Inc.
• Evans Analytical Group LLC
• LECO Corporation
• Phenomenome Discoveries Inc.
• AB Sciex
• BG Medicine Inc.
• Biomark Diagnostics Inc.
• Chenomx Inc.
• Creative Proteomics
• Evotec A.G
• Merck kgaA
• Southern Research Company Inc.
• Alcami Corporation
• Charles River Laboratories International Inc.
• Eremid Genomic Services LLC
• Metabowerke GmbH
• Metabolomic Diagnostics
• Phenomenex Inc.
What Is The Most Dominant Region In The Metabolomics Market?
North America was the largest region in the metabolomics market in 2023. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
